These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1025 related items for PubMed ID: 23737041

  • 1. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.
    Chua TC, Quinn LE, Zhao J, Morris DL.
    J Surg Oncol; 2013 Aug; 108(2):81-8. PubMed ID: 23737041
    [Abstract] [Full Text] [Related]

  • 2. Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis.
    Glockzin G, von Breitenbuch P, Schlitt HJ, Piso P.
    J Surg Oncol; 2013 May; 107(6):574-8. PubMed ID: 22833286
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.
    Vaira M, Robella M, Mellano A, Sottile A, De Simone M.
    Int J Hyperthermia; 2014 Dec; 30(8):565-9. PubMed ID: 25430988
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
    Klaver YL, Chua TC, Verwaal VJ, de Hingh IH, Morris DL.
    J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508
    [Abstract] [Full Text] [Related]

  • 9. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
    Canbay E, Mizumoto A, Ichinose M, Ishibashi H, Sako S, Hirano M, Takao N, Yonemura Y.
    Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
    [Abstract] [Full Text] [Related]

  • 10. Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: a case-matched study.
    Leapman MS, Jibara G, Tabrizian P, Franssen B, Yang MJ, Romanoff A, Hall SJ, Palese M, Sarpel U, Hiotis S, Labow D.
    Ann Surg Oncol; 2014 Apr; 21(4):1153-8. PubMed ID: 24322531
    [Abstract] [Full Text] [Related]

  • 11. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high volume disease and cure rate.
    Cashin PH, Dranichnikov F, Mahteme H.
    J Surg Oncol; 2014 Aug; 110(2):203-6. PubMed ID: 24846340
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA).
    Milovanov V, Sardi A, Ledakis P, Aydin N, Nieroda C, Sittig M, Nunez M, Gushchin V.
    Eur J Surg Oncol; 2015 May; 41(5):707-12. PubMed ID: 25633641
    [Abstract] [Full Text] [Related]

  • 15. Hyperthermic intraperitoneal chemotherapy for the treatment of recurrent ovarian cancer in elderly women.
    Delotte J, Arias T, Guerin O, Boulahssass R, Bereder I, Bongain A, Benchimol D, Bereder JM.
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):435-9. PubMed ID: 25675854
    [Abstract] [Full Text] [Related]

  • 16. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Van Der Speeten K, Morris DL.
    J Clin Oncol; 2012 Jul 10; 30(20):2449-56. PubMed ID: 22614976
    [Abstract] [Full Text] [Related]

  • 17. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Braam HJ, van Oudheusden TR, de Hingh IH, Nienhuijs SW, Boerma D, Wiezer MJ, van Ramshorst B.
    J Surg Oncol; 2014 Jun 10; 109(8):841-7. PubMed ID: 24619813
    [Abstract] [Full Text] [Related]

  • 18. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
    Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ.
    Eur J Surg Oncol; 2015 Mar 10; 41(3):396-9. PubMed ID: 25216980
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aggressive locoregional management of recurrent peritoneal sarcomatosis.
    Baumgartner JM, Ahrendt SA, Pingpank JF, Holtzman MP, Ramalingam L, Jones HL, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA.
    J Surg Oncol; 2013 Mar 10; 107(4):329-34. PubMed ID: 23386388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.